Gene · 1022
Papers3,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA SNHG1: role in tumorigenesis of multiple human cancers. | Cancer Cell Int | 2023 | 37684619 | PubTator, text mining | PubMed |
| Emerging systemic therapy options beyond CDK4/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer. | NPJ Breast Cancer | 2023 | 37684290 | PubTator, text mining | PubMed |
| CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. | J Virol | 2023 | 37671866 | PubTator, text mining | PubMed |
| Total network controllability analysis discovers explainable drugs for Covid-19 treatment. | Biol Direct | 2023 | 37670359 | PubTator, text mining | PubMed |
| Combined SPT and FCS methods reveal a mechanism of RNAP II oversampling in cell nuclei. | Sci Rep | 2023 | 37669988 | PubTator, text mining | PubMed |
| Association between cyclin-dependent kinase inhibitor 2B antisense RNA 1 and zinc finger homeobox 3 gene polymorphisms and COVID-19 severity. | BMC Infect Dis | 2023 | 37653506 | PubTator, text mining | PubMed |
| Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects. | Front Immunol | 2023 | 37649478 | PubTator, text mining | PubMed |
| Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 | 37644036 | PubTator, text mining | PubMed |
| MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. | J Exp Med | 2023 | 37642941 | PubTator, text mining | PubMed |
| BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1. | Viruses | 2023 | 37631985 | PubTator, text mining | PubMed |
| A New Diterpenoid of Indonesian Scoparia dulcis Linn: Isolation and Cytotoxic Activity against MCF-7 and T47D Cell Lines. | Molecules | 2023 | 37630212 | PubTator, text mining | PubMed |
| Targeted Therapy for EWS-FLI1 in Ewing Sarcoma. | Cancers (Basel) | 2023 | 37627063 | PubTator, text mining | PubMed |
| Small Cell Lung Cancer: Emerging Targets and Strategies for Precision Therapy. | Cancers (Basel) | 2023 | 37627044 | PubTator, text mining | PubMed |
| Coming of Age: Targeting Cyclin K in Cancers. | Cells | 2023 | 37626854 | PubTator, text mining | PubMed |
| The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma. | Cell Death Dis | 2023 | 37620336 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer. | Sci Rep | 2023 | 37612452 | PubTator, text mining | PubMed |
| MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma. | J Exp Clin Cancer Res | 2023 | 37599362 | PubTator, text mining | PubMed |
| Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma. | Front Immunol | 2023 | 37593739 | PubTator, text mining | PubMed |
| Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency. | Virus Res | 2023 | 37591314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1022/papers?page=18